Back to News
Market Impact: 0.25

Trump and Netanyahu meeting at Mar-a-Lago to discuss Gaza peace plan

Geopolitics & WarElections & Domestic PoliticsInfrastructure & Defense

President Trump hosted Israeli Prime Minister Benjamin Netanyahu at Mar-a-Lago on Dec. 29, 2025 to press the second phase of a Gaza peace plan focused on Hamas disarmament and transitional governance; the visit followed meetings by U.S. envoys with Qatar, Egypt and Turkey and a prior meeting between Netanyahu and Secretary of State Marco Rubio. Hamas has not disarmed or returned all hostage remains, Israeli strikes have continued, and a ceasefire that took effect in November remains fragile since the Oct. 7, 2023 attack that killed about 1,200 and took 251 hostages — outcomes that sustain geopolitical risk and could weigh on regional risk sentiment.

Analysis

Market structure: A Trump-Netanyahu push toward a “second phase” in Gaza increases near-term optionality for defense contractors, energy and safe-haven assets. If negotiations stall, expect a 5–15% re-rating higher for U.S. and Israeli defense primes (pricing in continued kinetic operations); if a credible transitional governance emerges within 60–90 days, those same names could give back 10–20% as risk premia compress. Risk assessment: Tail risks include rapid regional escalation (Iran/Lebanon intervention) that could send Brent to $90–120/bbl within weeks and trigger a global growth shock, or a surprise rapid peace that reduces future defense procurement. Immediate horizon (days) = headline-driven volatility; short-term (weeks–months) = asset rotation into energy/defense and safe havens; long-term (quarters) = potential political/aid flows reshaping U.S. defense revenue streams. Trade implications: Tradeable opportunities favor convex option structures around headlines and relative-value plays: long selective defense and gold miners vs short travel/exposed EM FX; buy 1–3 month call spreads or straddles into scheduled announcements, and scale into spot equities only after 5–10% move confirms direction. Position sizing should assume 10–20% realized intraday swings around major statements. Contrarian angles: Consensus assumes persistent elevated defense demand — the market underprices a negotiated transitional authority that reduces Israeli domestic operations but increases U.S. security guarantees (offset to U.S. primes). If peace progresses, cyclicals and Israeli equities (Econ exposure via banks/airlines) may outperform by 8–15% over 3–6 months; the crowded defensive long could be vulnerable to a fast unwind.

AllMind AI Terminal

AI-powered research, real-time alerts, and portfolio analytics for institutional investors.

Request a Demo

Market Sentiment

Overall Sentiment

mildly negative

Sentiment Score

-0.25

Key Decisions for Investors

  • Establish a 2.5% portfolio long in RTX (RTX) and 1.5% long in LMT (LMT) split—use 3-month call spreads (buy 1 ATM +15% strike, sell 1 +30% strike) sized to limit max loss to 40% of premium; target +15–25% on spread within 3–6 months, stop-loss if premium falls 50% or headlines show credible peace breakthrough.
  • Open a dollar-neutral pair: long 1.5% position in GD (GD) vs short 1.5% position in JETS ETF (JETS) size-matched by dollar exposure; hold 1–3 months, take profit if GD outperforms JETS by 8% or cut if divergence reverses by 6%.
  • Allocate 1% to GLD and 0.5% to NEM (NEM) via 2–6 week options (buy 1-month ATM calls) as asymmetric tail-hedges; add if Brent breaches $85/bbl or if VIX spikes >25.
  • Short 1–2% exposure to U.S.-listed airline AAL (AAL) via options (buy 2–3 month 10% OTM puts) or short the stock for a max drawdown risk of 8%; thesis: route disruption and fuel shock if conflict escalates, unwind if ceasefire shows firm commitments within 30 days.
  • If Israeli transitional governance progress is confirmed within 60 days (hostage returns + agreed disarmament steps), trim defensive positions by 50% and rotate proceeds into Israeli equity proxies and EM cyclicals (consider small buys in EWII or regional ETFs) to capture an anticipated 8–15% mean reversion over 3–6 months.